Patria Private Equity Trust — Resilient portfolio awaiting recovery in exits

Patria Private Equity Trust (LSE: PPET)

Last close As at 03/11/2026

GBP6.06

— 0.00 (0.00%)

Market capitalisation

GBP881m

More on this equity

Research: Investment Companies

Patria Private Equity Trust — Resilient portfolio awaiting recovery in exits

Patria Private Equity Trust (PPET) delivered an estimated NAV total return (TR) of 4.4% in sterling terms in the nine months to end-June 2026 (9M26), supported by continued earnings growth across its underlying private equity (PE) portfolio. The share price TR was stronger at 13.2%, only slightly below the UK index’s 14.1%, as the discount to NAV narrowed from 34.4% at end-September 2025 to 29.3%. PPET’s realisations of £150.1m in 9M26 broadly matched drawdowns of £153.3m, despite weaker distributions in the latest quarter. Meanwhile, the trust maintained an active investment programme, making £228.7m of new commitments. Net gearing increased from 8.4% at end-September 2025 to 13.3% at end-June 2026, although PPET retained £230.7m of cash and undrawn credit facilities.

Written by

Milosz Papst

Director of Content, Investment Trusts

Investment companies

Listed private equity

4 November 2026

Price 606.00p
Market cap £880m
Shares in issue 145.4m
Code/ISIN PPET/GB0030474687
Primary exchange LSE
AIC sector Private equity
Financial year end 30 September
52-week high/low 637.1p 532.5p

Fund objective

PPET's investment objective is to achieve long-term total returns through investing in and managing a diverse portfolio of private equity investments, principally focused on the European mid-market.

Bull points

  • Focus on strong relationships with established, specialist European PE managers.
  • Increasing exposure to direct investments, including co-investments and Patria Co-investment Partnership Fund I, with favourable fee economics and greater control over capital deployment
  • High exposure to less cyclical sectors.

Bear points

  • Continued weak realisation environment.
  • PPET's software exposure may be affected by investor fears over AI disruption.
  • PPET has just started building a track record of successful exits from its direct portfolio.

Analyst

Milosz Papst
+44 (0)20 3077 5700

Patria Private Equity Trust is a research client of Edison Investment Research Limited

European PE exit markets remain selective

The recovery in PE exit activity remains uneven, with overall volumes still muted and driven by a few large transactions. European exit value fell in calendar Q326 by 25.2% q-o-q, according to PitchBook, even as global exit activity improved, suggesting that a broad-based recovery remains some way off. This may delay distributions from PPET's mature holdings, although its mid-market focus offers a range of potential exit routes, including sales to strategic buyers and larger PE funds. While the manager expects meaningful realisations in the near term, including from its maturing direct portfolio, we believe it possible that the broader European exit market recovery may take longer.

Why consider PPET now?

We consider PPET's main attractions to be its relationships with leading, increasingly sector-specialised European PE managers, its focus on mid-market businesses offering opportunities for operational value creation and its diversified exposure to predominantly profitable, cash-generative companies. These strengths have contributed to a 10-year annualised NAV TR of 12.6% to end-June 2026. PPET also offers a progressive quarterly dividend and NAV-accretive buybacks. The wide discount is a potential source of shareholder upside, with a sustained recovery in exits offering a catalyst for a re-rating, although its timing remains uncertain.

Not intended for persons in the EEA.

Underlying earnings growth continues to support NAV

PPET's 9M26 NAV TR of c 4.4% comprised 3.1% in H126 and a further 1.3% in Q326. On a rolling 12-month basis to end-June 2026, NAV TR was 9.3%. The underlying portfolio continued to appreciate despite a challenging environment for PE valuations, returning 2.7% in constant currency in H126 and 2.6% in Q326, equivalent to c 5.4% on a compounded basis (see Exhibit 2). Fund secondaries led with an estimated 9M26 return of c 10%, compared with c 5% for primary funds and direct investments. In Q326, adverse currency movements reduced the portfolio return from 2.6% in constant currency to 1.4% in sterling. NAV TR also reflects management and financing costs, other assets and liabilities, dividends and the accretion from buybacks.

Operating performance across PPET's largest holdings remained encouraging. Among the top 100 underlying companies, representing 59.1% of portfolio NAV, average revenue and EBITDA increased by 13.7% and 13.4% y-o-y, respectively, over the 12 months to end-March 2026 (the latest available data, see Exhibit 3). Their median valuation multiple declined from 13.7x EBITDA at end-September 2025 to 13.4x at end-March 2026, while median leverage was 4.0x EBITDA. While this may be subject to mix effects, we believe it still suggests that earnings growth, rather than rising valuation multiples, has been the principal support for portfolio appreciation. We consider this particularly relevant as higher financing costs across PE markets versus pre-2022 levels and selective buyer demand constrain the contribution from leverage and multiple expansion.

Software valuations remain an area to watch

Software has been a source of valuation pressure in 2026 following the correction in listed software stocks amid concerns about disruption from AI. Software companies accounted for 19.5% of PPET's portfolio value at end-March 2026, mainly in specialist B2B applications. The manager believes these businesses are relatively well-placed to manage AI disruption given their high switching costs, proprietary data and integration into customers' workflows. We agree that these characteristics may provide competitive advantages but believe the impact on pricing power and long-term growth will vary considerably across individual businesses.

Visma, PPET's largest software holding at 2.2% of NAV at end-June, provides encouraging evidence of operating momentum. Its annualised recurring revenue rose by 18.7% y-o-y to €3.1bn in H126, including 13.0% organic growth, while adjusted EBITDA increased by 19.2% y-o-y. Customers accounting for 40% of recurring revenue have access to embedded AI capabilities, although this does not represent revenue generated directly by AI. Elsewhere in the portfolio, the discount retailer Action (PPET’s third-largest underlying portfolio company making up 1.6% of end-June 2026 NAV) reported sales and operating EBITDA growth of 14% and 13% y-o-y, respectively, for the six months to end-June 2026.

Realisations broadly matched drawdowns in 9M26

PPET generated realisations of £150.1m in 9M26, compared with c £148.3m in 9M25 and equivalent to c 12% of opening NAV. This included £131.0m of distributions from underlying investments (9M25: c £121.6m) and £19.1m from the partial secondary sale of its direct investment in Action (9M25 secondary sales: £26.7m). Drawdowns were slightly lower y-o-y at £153.3m (9M25: c £164.0m), resulting in a modest net portfolio investment outflow of £3.2m, compared with £15.7m in the prior-year period. Excluding secondary-sale proceeds, ordinary distributions alone were £22.3m below drawdowns. Even so, we consider the broadly balanced nine-month cash flows encouraging given the subdued exit environment.

As shown in Exhibit 1, quarterly distributions and capital calls are inherently uneven. Ordinary distributions slowed to £24.5m in Q326, from £43.8m in the preceding quarter, while drawdowns reached £57.7m. We would caution against extrapolating the latest quarter, given stronger distributions earlier in the financial year. PPET has also demonstrated its ability to generate liquidity through selective secondary sales, although these are distinct from distributions following exits of underlying portfolio companies.

Recent exits provide some valuation reassurance

Several realisations offer evidence of the valuations achieved for selected underlying assets. In H126, PPET sold its direct stake in Spanish food retailer Uvesco for £15.1m, realising 2.1x invested capital after a four-year holding period. This was its second completed full exit from the direct investment portfolio. PPET also received £19.1m from a partial sale of Action at its end-December 2025 carrying value, while retaining exposure to the business. Other notable realisations included Froneri, Etraveli and Clario.

In H126 (the latest available data), underlying portfolio-company exits achieved an average uplift of 4.8% to their carrying values two quarters earlier, compared with 18.9% in H125. The realised return also declined to 1.8x cost from 2.6x. Although positive uplifts provide some reassurance about PPET's carrying values, the reduction highlights a more challenging environment for crystallising gains.

A mature portfolio offers potential for higher distributions

At end-June 2026, 47% of underlying portfolio-company value related to investments held for five years or more (see Exhibit 4), following several years of subdued PE exit activity. PPET's mid-market exposure and specialist manager relationships offer a range of potential exit routes. Nevertheless, these older investments are not necessarily all ready for sale: timing, buyer appetite and achievable prices remain uncertain. We would therefore view a broader range of completed disposals, rather than a few selected transactions, as stronger evidence that the exit backlog is clearing.

Financial flexibility supported continued investment

PPET maintained an active investment programme in 9M26, making £228.7m of new commitments, equivalent to c 18% of opening NAV. This included £125.4m in primary funds, £45.8m relating to fund secondaries and £57.5m in direct investment strategies. New commitments totalled £175.9m in H126 (H125: £136.2m), followed by a further £52.8m in Q326. We believe maintaining investment activity through the current cycle may provide exposure to attractive new vintages, as primary commitments are gradually deployed.

Continued focus on specialist mid-market managers

Recent primary commitments included Hg Mercury 5, Triton Smaller Mid-Cap III and, in Q326, Investindustrial Lower Mid-Market IV and two Seidler Equity Partners funds. The trust also acquired secondary interests through Project Captain and Project Hamachi. Within direct investment strategies, PPET committed £36.8m to Patria Co-investment Partnership Fund (PCPF) I alongside new direct investments in Omilia (conversational AI software), AlphaPet (premium pet food) and Bluu Unit (commercial heating, ventilation and air conditioning services). The Patria-managed co-investment fund is intended to provide more consistent deployment in direct investments; importantly, its value is excluded from PPET's own management fee calculation, avoiding double charging at the listed-company level. As a cornerstone investor, PPET has secured a favourable fee arrangement such that direct investments made via PCPF I will incur lower total fees than direct investments made directly by PPET. The trust’s listed-vehicle management fee is 0.95% of NAV, with no additional trust-level performance fee (its annualised ongoing charges ratio was 1.07% at end-June 2026).

At end-June, primary funds represented 64.0% of PPET's portfolio, direct investments 25.4% and secondaries 10.6%. The manager's 2030 target allocations are 50–60% primaries, 30–35% directs and 10–15% secondaries. We view this combination as providing useful flexibility in sourcing investments at different points in the cycle, although the intended increase in direct exposure will also make the trust's direct-exit track record more relevant over time. Given the maturing direct portfolio and the associated exit potential, continued deployment into direct opportunities will likely be necessary to raise the share of direct investments in PPET’s portfolio.

Liquidity headroom has narrowed

PPET's available liquidity, comprising cash and undrawn borrowing facilities, declined from £294.2m at end-September 2025 to £230.7m at end-June 2026 (see Exhibit 5). As a result, net gearing increased from 8.4% to 13.3% over the nine months, reflecting a reduction in cash balances and a smaller net reduction in drawn borrowings. Outstanding commitments increased from £759.3m to £810.6m, while available liquidity as a percentage of commitments fell from 38.7% to 28.5%. The manager's overcommitment ratio increased from 33.8% to 40.2%, remaining below the midpoint of its 30–65% target range.

PPET's £400m revolving credit facility matures in February 2028, with options to extend for up to two further years. In addition, the manager estimated that c £125m of investments were financed temporarily through facilities at underlying funds at end-March 2026 and expected much of this to be called over the next 12 months. These are part of existing commitments, not an additional obligation. Although calls are spread over several years, we believe a prolonged shortage of distributions would reduce the flexibility available for new investments, buybacks and dividends. The ability to moderate new commitments or pursue selective secondary disposals provides some mitigation.

Substantial discount offers potential shareholder upside

PPET's share price discount to NAV narrowed from 34.4% at end-September 2025 to 29.3% at end-June 2026. The last closing share price implies a discount of c 30.3% to the last reported NAV of 869p at end-June. This is wider than the average 10-year discount of c 25.5% and much wider than the average 9% discount to NAV at which secondary limited partnership buyout positions were traded in the global PE secondaries market in H126, according to Jefferies Global Secondary Market Review. We consider the wide discount to NAV as potentially attractive given PPET's diversified portfolio and long-term NAV record, while recognising that investors continue to require a margin of safety against private valuation uncertainty and subdued realisations.

Long-term NAV returns remain competitive

PPET's annualised NAV TR was 8.7% over five years and 12.6% over 10 years to end-June 2026. Its shorter-term record also compares well with that of selected listed PE peers. PPET's rolling one-year NAV TR to end-June 2026 of 9.3% ranks second among its peer group and is ahead of the peer average of 6.7% (see Exhibit 6). Its cumulative three-year NAV TR of c 20.5% was the highest in the group, compared with a peer average of 15.3%, while its five-year return was broadly comparable with peer averages and the 10-year return was slightly ahead of peer average.

Dividends and buybacks complement NAV growth

The board intends to increase the FY26 dividend to 18.4p per share, from 17.6p in FY25, a 4.5% rise that would mark the twelfth consecutive year of increases. The payment is split into four quarterly instalments of 4.6p per share, with the third declared for payment in October 2026 and a fourth expected in January 2027. The intended annual dividend currently represents a yield of c 3.0%. The board considers the dividend policy effectively an ongoing return of capital to shareholders at NAV, rather than a distribution necessarily covered by recurring investment income.

PPET also invested c £14.4m in share repurchases during 9M26, generating c 3.9p of NAV accretion per share for continuing shareholders. Buybacks continued after end-June. In August, the Takeover Panel granted a dispensation relating to Aberdeen's reported voting interest, removing a possible regulatory obstacle to further purchases. By 28 October 2026, the number of ordinary shares outstanding excluding treasury had declined to 145.2m. We view repurchases at a substantial discount as a useful means of enhancing NAV per share, but their scale needs to be balanced against outstanding fund commitments and the prospective returns on new investments.

General disclaimer and copyright

This report has been commissioned by Patria Private Equity Trust and prepared and issued by Edison, in consideration of a fee payable by Patria Private Equity Trust. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2026 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on Patria Private Equity Trust

View All

Latest from the Investment Companies sector

View All Investment Companies content

Research: Healthcare

BioVersys — RIV-CARE FPFV raises the bar

BioVersys has announced first patient first visit (FPFV) in RIV-CARE, its c 100-patient Phase IIb open-label study evaluating BV100-based combinations against best available therapy (BAT) in difficult-to-treat carbapenem-resistant Acinetobacter baumannii (CRAB) infections. The study complements the pivotal RIV-TARGET Phase III study and is focused on high-resistance Asian markets, where CRAB prevalence and unmet need are substantial. We see RIV-CARE as strategically important given the evolving treatment landscape for CRAB infections, with approvals of Fetroja (cefiderocol) and Xacduro in 2020 and 2023, respectively. With interim data expected in H127, RIV-CARE offers an earlier opportunity to assess BV100’s differentiation ahead of RIV-TARGET top-line data, expected in early 2028. Wellcome funding (c CHF14m) offsets around two-thirds of trial costs, making this a relatively capital-efficient exercise.

Continue Reading
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.